Xingang Cui

1.5k total citations
41 papers, 406 citations indexed

About

Xingang Cui is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Xingang Cui has authored 41 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 25 papers in Molecular Biology and 10 papers in Surgery. Recurrent topics in Xingang Cui's work include Renal cell carcinoma treatment (18 papers), Ferroptosis and cancer prognosis (13 papers) and Renal and related cancers (11 papers). Xingang Cui is often cited by papers focused on Renal cell carcinoma treatment (18 papers), Ferroptosis and cancer prognosis (13 papers) and Renal and related cancers (11 papers). Xingang Cui collaborates with scholars based in China, United States and Thailand. Xingang Cui's co-authors include Xiuwu Pan, Keqin Dong, Danfeng Xu, Yi Gao, Sishun Gan, Ming Chen, Chao Wang, Yushan Liu, Wenjin Chen and Weijie Chen and has published in prestigious journals such as Advanced Materials, Journal of Clinical Investigation and Nature Cell Biology.

In The Last Decade

Xingang Cui

36 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingang Cui China 12 183 149 107 88 83 41 406
Yanlong Yang China 14 188 1.0× 133 0.9× 123 1.1× 35 0.4× 99 1.2× 27 441
Tomoyuki Shimabukuro Japan 12 115 0.6× 127 0.9× 84 0.8× 44 0.5× 137 1.7× 30 394
Tomoya Fukawa Japan 11 164 0.9× 104 0.7× 60 0.6× 71 0.8× 116 1.4× 62 392
Angelika Terbuch Austria 13 149 0.8× 159 1.1× 103 1.0× 40 0.5× 120 1.4× 33 397
Theodore Stewart Gourdin United States 10 105 0.6× 133 0.9× 83 0.8× 34 0.4× 90 1.1× 39 374
Eiji Noda Japan 13 97 0.5× 110 0.7× 93 0.9× 66 0.8× 182 2.2× 60 515
Yushen Wu China 14 215 1.2× 114 0.8× 158 1.5× 72 0.8× 92 1.1× 25 532
Jane Nguyen United States 12 175 1.0× 258 1.7× 54 0.5× 24 0.3× 91 1.1× 54 401
Yuancheng Gou China 12 130 0.7× 108 0.7× 64 0.6× 31 0.4× 172 2.1× 16 395
Ling Lu China 14 197 1.1× 59 0.4× 78 0.7× 69 0.8× 35 0.4× 29 434

Countries citing papers authored by Xingang Cui

Since Specialization
Citations

This map shows the geographic impact of Xingang Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingang Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingang Cui more than expected).

Fields of papers citing papers by Xingang Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingang Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingang Cui. The network helps show where Xingang Cui may publish in the future.

Co-authorship network of co-authors of Xingang Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Xingang Cui. A scholar is included among the top collaborators of Xingang Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingang Cui. Xingang Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Rui, Ye Wang, Xiuwu Pan, et al.. (2025). Application of Ultra Micro Angiography in Differential Diagnosis of Renal Tumors. Journal of Ultrasound in Medicine.
2.
Guo, Chenyue, Rujuan Bao, Haiyan Huang, et al.. (2025). Diet-derived galactose reprograms hepatocytes to prevent T cell exhaustion and elicit antitumour immunity. Nature Cell Biology. 27(8). 1357–1366. 1 indexed citations
3.
Yang, Wei, Zhi-Zhang Yang, Jianwei Cao, et al.. (2025). One-dimensional nanosonosensitizer boosted multiple branches of immune responses against MHC-deficient immune-evasive urologic tumor. Science Advances. 11(5). eado7373–eado7373. 5 indexed citations
4.
Chen, Wenjin, Wei Yang, Xiangmin Zhang, et al.. (2024). DEPDC1 as a metabolic target regulates glycolysis in renal cell carcinoma through AKT/mTOR/HIF1α pathway. Cell Death and Disease. 15(7). 533–533. 10 indexed citations
6.
Chen, Jiaxin, Wenbin Guan, Yijun Tian, et al.. (2024). Novel model of pyroptosis-related molecular signatures for prognosis prediction of clear cell renal cell carcinoma patients. International Journal of Medical Sciences. 21(3). 496–507. 4 indexed citations
7.
Shao-jun, Chen, et al.. (2024). Impact of tumor multiplicity on the prognosis of patients with primary renal cell carcinoma: a SEER database analysis. Clinical and Experimental Medicine. 24(1). 194–194.
8.
Liu, Yifan, Bing-Nan Lu, Lei Wang, et al.. (2024). Construction and validation of a regulatory T cells-based classification of renal cell carcinoma: an integrated bioinformatic analysis and clinical cohort study. Cellular Oncology. 48(3). 591–615. 2 indexed citations
9.
Hu, Zhilin, Xiaoyan Yu, Rui Ding, et al.. (2023). Glycolysis drives STING signaling to facilitate dendritic cell antitumor function. Journal of Clinical Investigation. 133(7). 58 indexed citations
10.
Zhang, Shun, Hailong Liu, Chen Wang, et al.. (2023). LRRK2 aggravates kidney injury through promoting MFN2 degradation and abnormal mitochondrial integrity. Redox Biology. 66. 102860–102860. 14 indexed citations
12.
Wang, Chao, Keqin Dong, Yuning Wang, et al.. (2021). Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma. BMC Cancer. 21(1). 890–890. 8 indexed citations
13.
Zhu, Dawei, et al.. (2021). RNF43 is a novel tumor-suppressor and prognostic indicator in clear cell renal cell carcinoma. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 29(3). 159–174. 7 indexed citations
14.
Yang, Qiwei, Weiwei Chu, Wei Yang, et al.. (2020). Identification of RNA Transcript Makers Associated With Prognosis of Kidney Renal Clear Cell Carcinoma by a Competing Endogenous RNA Network Analysis. Frontiers in Genetics. 11. 540094–540094. 18 indexed citations
15.
Wang, Chao, Yan Li, Chuanmin Chu, et al.. (2018). Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma. EBioMedicine. 39. 255–264. 17 indexed citations
16.
Chen, Lu, Xiuwu Pan, Xingang Cui, et al.. (2015). Selection of personalized laparoscopic partial nephrectomy based on tumor characteristics: A preliminary study in a single center. International Journal of Surgery. 23. 46–51. 3 indexed citations
17.
Teng, Jingfei, Yi Gao, Ming Chen, et al.. (2014). Prognostic value of clinical and pathological factors for surgically treated localized clear cell renal cell carcinoma. Chinese Medical Journal. 127(9). 1640–1644. 24 indexed citations
18.
Wang, Guodong, et al.. (2011). The Surgical Treatment of Andersson Lesions Associated With Ankylosing Spondylitis. Orthopedics. 34(7). e302–6. 10 indexed citations
19.
Xu, Danfeng, Ming Chen, Yushan Liu, Yi Gao, & Xingang Cui. (2010). Non-functional paraganglioma of the urinary bladder: a case report. Journal of Medical Case Reports. 4(1). 216–216. 19 indexed citations
20.
Liu, Yushan, et al.. (2009). Retroperitoneal Laparoscopic Ureteroureterostomy for Retrocaval Ureter: Report of 7 Cases. Urology. 74(6). 1242–1245. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026